Sign up | Login with →


Has CLL Defined Me?

November 22, 2015 by Andrew Schorr

I had responded initially “no” because of the way I am able to live my life. Since 2010, I haven’t needed treatment. The only pill I take is vitamin D3 when I remember. I continue to work as a communications consultant and a medical journalist. I travel when and where I want. I have visited more than a dozen countries since my original diagnosis. Sounds like “no,” doesn’t it?[read more]


The Future of Ovarian Cancer Diagnosis Is Now — Through These 4 Strategies

November 11, 2015 by Judy Wolf

Significant improvements to the way ovarian cancer is screened, diagnosed, and treated are at our fingertips. These four strategies, however, will put them in our palms.[read more]

Healthcare at the GOP debate

November 3, 2015 by David E Williams

A synopsis of where the GOP candidates stand when it comes to healthcare: the good, the bad, and the neutral. Who do you agree with?[read more]

The Emotional Side of Cancer

November 3, 2015 by Andrew Schorr

An inspiring letter from a two-time survivor of pancreatic cancer. "In my cancer fight, I made a deliberate, difficult decision to stay upbeat."[read more]

Financial Assistance for Clinical Trials

September 16, 2015 by Joan Justice

Sometimes hospitals, research centers and pharmaceutical companies will cover the cost of treatment in a clinical trial. However, if the treatment is experimental or investigational, a patient may not receive insurance coverage. Insurance companies generally will cover what is considered the standard of care for a disease.[read more]

Clinical Trials Process: A Physician's View

September 8, 2015 by Joan Justice

Dr. Jeff Sharman

Dr. Sharman is convinced that although research adds to a physician’s workload, it enlivens a practice and adds to productivity[read more]

Frank Discussions About Oral Cancer Therapies

June 8, 2015 by Andrew Schorr

Oral cancer therapies seem poised to revolutionize cancer care for many cancer types. More convenient, more effective, and often less toxic. But they are quite expensive—in many cases, more than $100,000 a year per patient. And some experts have been discussing combining two drugs. We must talk more about cost and not just echo the mantra of researchers who are “excited” about trial results.[read more]

Schmoozing for Cancer, Part II

May 20, 2015 by Andrew Schorr

If you become part of the Patient Power community, we don’t schmooze with you once but all the time. It’s the way we interact. And we believe it’s unique. We talk with people, not at them, and we want to know everyone’s story. That’s why our town meetings are not seminars, they are conversations.[read more]


Virtual Meet-Ups for Cancer Patients

April 14, 2015 by Joan Justice

Patient Cafe™

Now, cancer patients can meet virtually and share stories. With the Patient Cafe™, a virtual meet-up program from the Patient Empowerment Network, cancer patients sign up to meet others with the same cancer condition. The program is free and all the participants need is a good internet connection.[read more]

Cancer Drugs: Why the High and Rising Prices?

April 10, 2015 by David E Williams

Stuart Miles /

While politicians wring their hands, pricing strategists at pharma and biotech companies take action by charging high and rising prices for products for life-threatening illnesses. Cancer is Exhibit A, with many drugs costing more than $100,000 per year of treatment. I don’t expect any dramatic clampdown on cancer drug prices in the near term.[read more]

Lucky Us! How New Medicines Are Cheating Death

March 20, 2015 by Andrew Schorr

Patient Power lung cancer town meeting

I am meeting people who have the good fortune to be sick at a time when there are truly breakthroughs to give them back better health. When you meet scores of people like this, you feel grateful to the often unseen researchers who made this happen.[read more]

Celebrating Partnerships in Cancer

March 9, 2015 by Andrew Schorr

Powerful Patients at Moffitt Cancer Center

I have written many times here about my frustration when groups that are supposed to have a devotion to cancer patients as their top priority get sidetracked by egos, distrust of one another, bureaucratic procedures and turf wars. But I am happy to report some instances now when groups are working together as true partners.[read more]